300 related articles for article (PubMed ID: 34445382)
1. Recent Applications of Retro-Inverso Peptides.
Doti N; Mardirossian M; Sandomenico A; Ruvo M; Caporale A
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445382
[TBL] [Abstract][Full Text] [Related]
2. Cross-reactivity of antibodies to retro-inverso peptidomimetics with the parent protein histone H3 and chromatin core particle. Specificity and kinetic rate-constant measurements.
Benkirane N; Guichard G; Van Regenmortel MH; Briand JP; Muller S
J Biol Chem; 1995 May; 270(20):11921-6. PubMed ID: 7744843
[TBL] [Abstract][Full Text] [Related]
3. Antigenic mimicry of natural L-peptides with retro-inverso-peptidomimetics.
Guichard G; Benkirane N; Zeder-Lutz G; van Regenmortel MH; Briand JP; Muller S
Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9765-9. PubMed ID: 7937888
[TBL] [Abstract][Full Text] [Related]
4. The potential of retro-inverso peptides as synthetic vaccines.
Muller S; Benkirane N; Guichard G; Van Regenmortel MH; Brown F
Expert Opin Investig Drugs; 1998 Sep; 7(9):1429-38. PubMed ID: 15992041
[TBL] [Abstract][Full Text] [Related]
5. The design, synthesis and application of stereochemical and directional peptide isomers: a critical review.
Fischer PM
Curr Protein Pept Sci; 2003 Oct; 4(5):339-56. PubMed ID: 14529528
[TBL] [Abstract][Full Text] [Related]
6. Limitations of peptide retro-inverso isomerization in molecular mimicry.
Li C; Pazgier M; Li J; Li C; Liu M; Zou G; Li Z; Chen J; Tarasov SG; Lu WY; Lu W
J Biol Chem; 2010 Jun; 285(25):19572-81. PubMed ID: 20382735
[TBL] [Abstract][Full Text] [Related]
7. Functional consequences of retro-inverso isomerization of a miniature protein inhibitor of the p53-MDM2 interaction.
Li C; Zhan C; Zhao L; Chen X; Lu WY; Lu W
Bioorg Med Chem; 2013 Jul; 21(14):4045-50. PubMed ID: 23660015
[TBL] [Abstract][Full Text] [Related]
8. The partial retro-inverso modification: a road traveled together.
Chorev M
Biopolymers; 2005; 80(2-3):67-84. PubMed ID: 15729688
[TBL] [Abstract][Full Text] [Related]
9. Cyclic retro-inverso dipeptides with two aromatic side chains. II. Conformational analysis.
Yamazaki T; Nunami K; Goodman M
Biopolymers; 1991 Nov; 31(13):1513-28. PubMed ID: 1814501
[TBL] [Abstract][Full Text] [Related]
10. Structural comparison between retro-inverso and parent peptides: molecular basis for the biological activity of a retro-inverso analogue of the immunodominant fragment of VP1 coat protein from foot-and-mouth disease virus.
Carver JA; Esposito G; Viglino P; Fogolari F; Guichard G; Briand JP; Van Regenmortel MH; Brown F; Mascagni P
Biopolymers; 1997 Apr; 41(5):569-90. PubMed ID: 9095678
[TBL] [Abstract][Full Text] [Related]
11. Mimicry of viral epitopes with retro-inverso peptides of increased stability.
Benkirane N; Guichard G; Briand JP; Muller S; Brown F; Van Regenmortel MH
Dev Biol Stand; 1996; 87():283-91. PubMed ID: 8854029
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the solution conformations of a human immunodeficiency virus peptidomimetic and its retro-inverso isomer using 1H NMR spectroscopy.
Higgins KA; Bicknell W; Keah HH; Hearn MT
J Pept Res; 1997 Dec; 50(6):421-35. PubMed ID: 9440043
[TBL] [Abstract][Full Text] [Related]
13. On the immunogenic properties of retro-inverso peptides. Total retro-inversion of T-cell epitopes causes a loss of binding to MHC II molecules.
Hervé M; Maillere B; Mourier G; Texier C; Leroy S; Ménez A
Mol Immunol; 1997 Feb; 34(2):157-63. PubMed ID: 9188848
[TBL] [Abstract][Full Text] [Related]
14. A retro-inverso analog mimics the cognate peptide epitope of a CD4+ T cell clone.
Bartnes K; Hannestad K; Guichard G; Briand JP
Eur J Immunol; 1997 Jun; 27(6):1387-91. PubMed ID: 9209489
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and evaluation of
Kumar Sharma A; Sharma R; Dev Sarma H; Mukherjee A; Das T; Satpati D
Bioorg Chem; 2023 Nov; 140():106761. PubMed ID: 37586132
[TBL] [Abstract][Full Text] [Related]
16. Integrin αvβ3 targeting activity study of different retro-inverso sequences of RGD and their potentiality in the designing of tumor targeting peptides.
Liu Y; Mei L; Yu Q; Zhang Q; Gao H; Zhang Z; He Q
Amino Acids; 2015 Dec; 47(12):2533-9. PubMed ID: 26173509
[TBL] [Abstract][Full Text] [Related]
17. In vivo T helper cell response to retro-inverso peptidomimetics.
Mézière C; Viguier M; Dumortier H; Lo-Man R; Leclerc C; Guillet JG; Briand JP; Muller S
J Immunol; 1997 Oct; 159(7):3230-7. PubMed ID: 9317121
[TBL] [Abstract][Full Text] [Related]
18. Retro-inverso d-peptide-modified hyaluronic acid/bioreducible hyperbranched poly(amido amine)/pDNA core-shell ternary nanoparticles for the dual-targeted delivery of short hairpin RNA-encoding plasmids.
Gu J; Chen X; Fang X; Sha X
Acta Biomater; 2017 Jul; 57():156-169. PubMed ID: 28442415
[TBL] [Abstract][Full Text] [Related]
19. Enantiomer-specific bioactivities of peptidomimetic analogues of mastoparan and mitoparan: characterization of inverso mastoparan as a highly efficient cell penetrating peptide.
Jones S; Howl J
Bioconjug Chem; 2012 Jan; 23(1):47-56. PubMed ID: 22148546
[TBL] [Abstract][Full Text] [Related]
20. Enhanced immunogenicity and cross-reactivity of retro-inverso peptidomimetics of the major antigenic site of foot-and-mouth disease virus.
Muller S; Guichard G; Benkirane N; Brown F; Van Regenmortel MH; Briand JP
Pept Res; 1995; 8(3):138-44. PubMed ID: 7670228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
